4[1]Johnson KA, Kijewski MF, Becker JA, et at. Quantitative brain SPECT in Alzheimer′s disease and normal aging[J]. J Nucl Med, 1993, 34: 2 044-2 048.
5[2]Mattman A, Feldman H, Forster B, et al. Regional HMPAO SPECT and CT measurements in the diagnosis of Alzheimer′s disease[J]. Can J Neurol Sci, 1997,24:22-30.
6[3]Small GW, MazziottTC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk familial Alzheimer′s disease[J].JAMA,1995:273-947.
7[5]Claus JJ, BretelerMM, E Hasan D, et al. Regional cerebral lood flow and cerebrovascular risk factors in the elderly population[J]. Neurobiol Aging, 1998, 19:57-64.
8[6]De la TorreJC. Impaired cerebromicrovascular perfusion: summary of evidence in support of its causality in Alzheimer′s disease[J]. Ann NY Acad Sci,2000,924: 136- 152.
9Johnson KA, Kijewski MF, Becker JA,et al. Quantitative brain SPECT in Alzheimer's disease and normal aging[J]. J Nucl Med,1993,34 : 2044-2048.
10Small GW,Mazziott TC,Collins MT,et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk familial Alzheimer's disease[J]. JAMA,1995,273-947.
